Pfizer (PFE)

$27.81 0.00 (0.00%)

19:00 EDT PFE Stock Quote Delayed 30 Minutes

Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth

By Josh Enomoto, InvestorPlace Contributor May 6, 2024

With the sharp rise in the equities space since the beginning of the year, it’s been difficult to find undervalued growth stocks. Still, there are…

3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market

3 Contrarian Stocks That Could Make You a Fortune (If You Dare)

PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024

Volume:

Previous Close -

Market Cap 155.92B

PE Ratio 75.16

EPS 0.37

Volume (Avg. Vol.) 23,703

Day's Range -

52-Week Range $25.20 - $40.37

Dividend & Yield $1.64 (5.90%)

PFE Stock Predictions, Articles, and Pfizer News

From InvestorPlace
From the Web

3 Pharma Stocks With the Potential to Make You an Overnight Millionaire

By Chandler Capital, InvestorPlace Contributor May 1, 2024

As a result of their enduring significance in healthcare, the pharma industry offers both short and long term opportunities in pharma stocks.

7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 30, 2024

Safe haven stocks offer stability even during market fall in communication, financials, healthcare, energy and consumer staples.

3 Dividend Stocks to Buy on the Dip: April 2024

By Josh Enomoto, InvestorPlace Contributor Apr 29, 2024

At first glance, the concept of dividend stocks to buy on the dip might clash with your instincts. Right now, the combination of robust employment…

7 Dividend Stocks to Buy Now for Steady Returns in Any Market

By Vandita Jadeja Apr 27, 2024

Passive investors pay attention! Invest in the best of the best with these seven dividend stocks for steady returns.

The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 24, 2024

Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.

3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge

By Faisal Humayun, InvestorPlace Contributor Apr 23, 2024

These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.

3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years

By Faisal Humayun, InvestorPlace Contributor Apr 22, 2024

These are the undervalued blue-chip stocks to buy as they represent fundamentally strong ideas poised for accelerated growth.

The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 17, 2024

Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media.

7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape

By Josh Enomoto, InvestorPlace Contributor Apr 10, 2024

With rising concerns in the market potentially forcing a strategic shift, investors may want to consider healthcare stocks. No matter what happens, people need access…

3 Dirt-Cheap Stocks That Could Make You Filthy Rich

By Muslim Farooque, InvestorPlace Contributor Apr 9, 2024

Cheap stocks offer a silver lining as the Fed takes a cautious stance, presenting opportunities for savvy investors.

The 3 Most Undervalued Healthcare Stocks to Buy in April 2024

By Joel Baglole, InvestorPlace Contributor Apr 8, 2024

Health insurers, pharmaceutical companies and medical device manufacturers have all been knocked lower as an aging population drives up medical costs and companies struggle to maintain their profit margins.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor Apr 5, 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

The Comeback Kids: 7 Stocks Ready to Rise from the Ashes

By Yiannis Zourmpanos, InvestorPlace Contributor Apr 4, 2024

Discover seven resilient comeback stocks thriving across diverse sectors, from pharma to tech, poised for growth amid economic flux.

Unbeatable Blue Chips: 7 Must-Own Stocks for Every Portfolio

By Alex Sirois, InvestorPlace Contributor Apr 1, 2024

Blue chip stocks are excellent wealth builders and a must own for every portfolio of every size and investment style.

Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries

By Josh Enomoto, InvestorPlace Contributor Apr 1, 2024

It’s an interesting time in the market, which may bode well for conservative ideas found among blue-chip stocks. Underlying this category are some of the…